Guardant Health, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Guardant Health, Inc. (GH), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are GH insiders buying or selling?
Guardant Health, Inc. insiders reported 8 open-market buys ($65.2M) and 239 sells ($2.9B) across 247 Form 4 filings — a net selling position of $2.8B.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 16, 2026)
Insider sentiment
Net sellingNet insider flow of $2.8B in net selling.
Recent GH insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Musa Tariq | Director | Sale | 116 | $163.29 | $18.9K |
| Jun 30, 2026 | Kumud Kalia | Chief Information Officer | Sale | 600 | $131.18 | $78.7K |
| Jun 30, 2026 | Amirali Talasaz | Co-Chief Executive Officer | Sale | 260.0K | $151.20 | $39.3M |
| Jun 23, 2026 | Musa Tariq | Director | Sale | 2.0K | $131.16 | $255.9K |
| Jun 23, 2026 | Myrtle S Potter | Director | Sale | 1.6K | $131.16 | $204.1K |
| Jun 16, 2026 | Musa Tariq | Director | Sale | 116 | $130.19 | $15.1K |
| Jun 15, 2026 | Kumud Kalia | Chief Information Officer | Sale | 3.4K | $130.24 | $445.2K |
| Jun 12, 2026 | Kumud Kalia | Chief Information Officer | Sale | 5.0K | $130.41 | $652.0K |
| Jun 8, 2026 | Eltoukhy Helmy | Co-Chief Executive Officer | Sale | 100.0K | $126.30 | $12.6M |
| Jun 8, 2026 | Michael Brian Bell | Chief Financial Officer | Sale | 2.0K | $128.62 | $257.2K |
| Jun 5, 2026 | Steve E. Krognes | Director | Sale | 9.3K | $132.51 | $1.2M |
| Jun 4, 2026 | Meghan V. Joyce | Director | Sale | 10.0K | $126.98 | $1.3M |
| May 29, 2026 | Medina Manuel Hidalgo | Director | Sale | 1.0K | $130.06 | $130.1K |
| May 28, 2026 | John G. Saia | Chief Legal Officer | Sale | 10.0K | $125.08 | $1.3M |
| May 26, 2026 | Chris Freeman | Chief Commercial Officer | Sale | 24.4K | $118.67 | $2.9M |
| May 22, 2026 | John G. Saia | Chief Legal Officer | Sale | 20.0K | $106.51 | $2.1M |
| May 22, 2026 | Amirali Talasaz | Co-Chief Executive Officer | Sale | 210.0K | $109.89 | $23.1M |
| May 22, 2026 | Ian T Clark | Director | Sale | 6.9K | $106.90 | $735.0K |
| May 22, 2026 | Medina Manuel Hidalgo | Director | Sale | 1.3K | $107.09 | $133.9K |
| May 19, 2026 | Musa Tariq | Director | Sale | 116 | $95.96 | $11.1K |
| May 13, 2026 | Amirali Talasaz | Co-Chief Executive Officer | Sale | 50.0K | $100.32 | $5.0M |
| Apr 16, 2026 | Musa Tariq | Director | Sale | 116 | $84.83 | $9.8K |
| Apr 7, 2026 | Terilyn J. Monroe | Chief People Officer | Sale | 3.8K | $92.68 | $355.1K |
| Mar 19, 2026 | Musa Tariq | Director | Sale | 348 | $88.09 | $30.7K |
| Mar 17, 2026 | Michael Brian Bell | Chief Financial Officer | Sale | 3.0K | $87.04 | $261.1K |
Showing the 25 most recent of 247 Form 4 filings for Guardant Health, Inc..
Most active GH insiders
- Ian T Clark41 filings
- Amirali Talasaz40 filings
- Stanley J Meresman36 filings
- Eltoukhy Helmy23 filings
- Musa Tariq20 filings
Ask anything about GH insider activity
Use Trabud's AI agent to query Guardant Health, Inc.'s Form 4 history in plain English — "Show me GH CEO purchases this year" or compare it against any other ticker.
Open the AI agentGH insider trading FAQ
Are Guardant Health, Inc. insiders buying or selling?
Across 247 SEC Form 4 filings, Guardant Health, Inc. (GH) insiders reported 8 open-market purchases totaling $65.2M and 239 sales totaling $2.9B. That is a net selling position of $2.8B.
How many insiders trade GH stock?
23 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Guardant Health, Inc.. The most recent filing was accepted on Jul 16, 2026.
Where does Trabud get GH insider trading data?
All GH insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.